Core Insights - Ventas (VTR) shares have increased by 24.8% over the past six months, outperforming the industry growth of 7.6% [1] - The company is well-positioned to benefit from rising healthcare spending and an aging population, particularly in its senior housing operating portfolio [1][5] - Ventas has made accretive investments in its research portfolio and maintains a solid balance sheet, which supports future growth [1][10] Financial Performance - In the fourth quarter of 2025, Ventas reported normalized funds from operations (FFO) per share of 89 cents, a 9.9% increase from the previous year [2] - The same-store cash net operating income (NOI) for the senior housing operating portfolio (SHOP) grew by 15.4% year-over-year in Q4 2025, with expectations of 13% to 17% growth in 2026 [6][7] - The outpatient medical and research (OM&R) portfolio saw a 3.7% same-store cash NOI growth in Q4 2025, with a projected growth of 2.0% to 3.0% in 2026 [8] Market Position and Strategy - The U.S. population aged 80 years and above is expected to grow by 28% over the next five years, increasing demand for senior housing [5] - Ventas operates in markets with favorable demographics and strong net absorption, which are expected to drive growth [6] - The company follows a disciplined capital-recycling strategy, selling non-core assets and reinvesting in premium acquisitions, with $223.2 million from asset sales in 2025 and $2.3 billion spent on acquiring 52 senior housing communities [9] Liquidity and Financial Health - As of December 31, 2025, Ventas had approximately $5.3 billion in liquidity, including cash and available credit [10] - The company's net debt to further adjusted EBITDA improved to 5.2X from 6.0X year-over-year, with expectations for continued improvement in leverage [10]